NorthWest Biotherapeutics Inc (NWBO)

[beartrap12]

Senti, UCLA is a university research lab that used an autologous DC in their clinical trials that Dr. Linda Liau has confirmed was/is DCVax-L. We know there are other research labs/clinics that have used an autologous DC product in their vaccines that sounds exactly like the UCLA product and exactly like DCVax-L. So, do you believe these were also DCVax-L products used with or without NWBO consent?
When this debate surfaced on this board a year or so ago, I didn't initially compare UCLA's relationship to DCax-L to those of places like the Mayo clinic or Moffett center. I thought UCLA was different because NWBO in-licensed Dr. Liau's work from UCLA. Since dstock and others revealed these "other" places using DCVax-L- similar vaccines, there's been quite some controversy. But recently I took a step back and compared UCLA with the other clinical trials by other clinics/labs and have to wonder "what is the difference", other than that we in-licensed UCLA and we developed it into a commercial product? Afterall, we could any day in-license the work from Mayo and Moffitt or even the Czech Republic clinics?
I don't know if you've commented on this before, but I'd like to hear your opinion.
TIA, Senti! And thanks for all your work for this board and the longs!